Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

Harnessing radiation to improve immunotherapy: better with particles?

Durante M, Formenti S.

Br J Radiol. 2019 Jul 22:20190224. doi: 10.1259/bjr.20190224. [Epub ahead of print]

PMID:
31317768
2.

Biological Cardiac Tissue Effects of High-Energy Heavy Ions - Investigation for Myocardial Ablation.

Rapp F, Simoniello P, Wiedemann J, Bahrami K, Grünebaum V, Ktitareva S, Durante M, Lugenbiel P, Thomas D, Lehmann HI, Packer DL, Graeff C, Fournier C.

Sci Rep. 2019 Mar 21;9(1):5000. doi: 10.1038/s41598-019-41314-x.

3.

A new facility for proton radiobiology at the Trento proton therapy centre: Design and implementation.

Tommasino F, Rovituso M, Bortoli E, La Tessa C, Petringa G, Lorentini S, Verroi E, Simeonov Y, Weber U, Cirrone P, Schwarz M, Durante M, Scifoni E.

Phys Med. 2019 Feb;58:99-106. doi: 10.1016/j.ejmp.2019.02.001. Epub 2019 Feb 11.

PMID:
30824157
4.

Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.

Palma G, Monti S, Xu T, Scifoni E, Yang P, Hahn SM, Durante M, Mohan R, Liao Z, Cella L.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1124-1132. doi: 10.1016/j.ijrobp.2019.02.039. Epub 2019 Feb 26.

PMID:
30822531
5.

Hibernation and Radioprotection: Gene Expression in the Liver and Testicle of Rats Irradiated under Synthetic Torpor.

Tinganelli W, Hitrec T, Romani F, Simoniello P, Squarcio F, Stanzani A, Piscitiello E, Marchesano V, Luppi M, Sioli M, Helm A, Compagnone G, Morganti AG, Amici R, Negrini M, Zoccoli A, Durante M, Cerri M.

Int J Mol Sci. 2019 Jan 16;20(2). pii: E352. doi: 10.3390/ijms20020352.

6.

Proton beam therapy in Europe: more centres need more research.

Durante M.

Br J Cancer. 2019 Apr;120(8):777-778. doi: 10.1038/s41416-018-0329-x. Epub 2018 Dec 11. No abstract available.

PMID:
30531831
7.

Report of a National Cancer Institute special panel: Characterization of the physical parameters of particle beams for biological research.

Durante M, Paganetti H, Pompos A, Kry SF, Wu X, Grosshans DR.

Med Phys. 2019 Feb;46(2):e37-e52. doi: 10.1002/mp.13324. Epub 2018 Dec 31.

PMID:
30506898
8.

Experimental Assessment of Lithium Hydride's Space Radiation Shielding Performance and Monte Carlo Benchmarking.

Schuy C, Tessa C, Horst F, Rovituso M, Durante M, Giraudo M, Bocchini L, Baricco M, Castellero A, Fioreh G, Weber U.

Radiat Res. 2019 Feb;191(2):154-161. doi: 10.1667/RR15123.1. Epub 2018 Nov 30.

PMID:
30499384
9.

Radiogenomics.

Story MD, Durante M.

Med Phys. 2018 Nov;45(11):e1111-e1122. doi: 10.1002/mp.13064. Review.

PMID:
30421807
10.

Radiation quality and intra-chromosomal aberrations: Size matters.

Cornforth MN, Durante M.

Mutat Res Genet Toxicol Environ Mutagen. 2018 Dec;836(Pt A):28-35. doi: 10.1016/j.mrgentox.2018.05.002. Epub 2018 May 5. Review.

PMID:
30389158
11.

Accelerator-Based Tests of Shielding Effectiveness of Different Materials and Multilayers using High-Energy Light and Heavy Ions.

Giraudo M, Schuy C, Weber U, Rovituso M, Santin G, Norbury JW, Tracino E, Menicucci A, Bocchini L, Lobascio C, Durante M, Tessa C.

Radiat Res. 2018 Nov;190(5):526-537. doi: 10.1667/RR15111.1. Epub 2018 Aug 20.

PMID:
30124374
12.

Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.

Durante M, Formenti SC.

Front Oncol. 2018 May 29;8:192. doi: 10.3389/fonc.2018.00192. eCollection 2018. Review.

13.

Heavy Charged Particles: Does Improved Precision and Higher Biological Effectiveness Translate to Better Outcome in Patients?

Durante M, Debus J.

Semin Radiat Oncol. 2018 Apr;28(2):160-167. doi: 10.1016/j.semradonc.2017.11.004. Review.

PMID:
29735192
15.

Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma.

Brownstein JM, Wisdom AJ, Castle KD, Mowery YM, Guida P, Lee CL, Tommasino F, Tessa C, Scifoni E, Gao J, Luo L, Campos LDS, Ma Y, Williams N, Jung SH, Durante M, Kirsch DG.

Mol Cancer Ther. 2018 Apr;17(4):858-868. doi: 10.1158/1535-7163.MCT-17-0965. Epub 2018 Feb 7.

16.

Editorial: Charged Particles in Oncology.

Durante M, Cucinotta FA, Loeffler JS.

Front Oncol. 2017 Dec 8;7:301. doi: 10.3389/fonc.2017.00301. eCollection 2017. No abstract available.

17.

Immobilization for carbon ion beam ablation of cardiac structures in a porcine model.

Prall M, Eichhorn A, Richter D, Lehmann HI, Constantinescu A, Kaderka R, Lugenbiel P, Thomas D, Bert C, Packer DL, Durante M, Graeff C.

Phys Med. 2017 Nov;43:134-139. doi: 10.1016/j.ejmp.2017.10.016. Epub 2017 Nov 8.

PMID:
29195556
18.

Faster and safer? FLASH ultra-high dose rate in radiotherapy.

Durante M, Bräuer-Krisch E, Hill M.

Br J Radiol. 2018 Feb;91(1082):20170628. doi: 10.1259/bjr.20170628. Epub 2017 Dec 15.

19.

Treatment planning with intensity modulated particle therapy for multiple targets in stage IV non-small cell lung cancer.

Anderle K, Stroom J, Vieira S, Pimentel N, Greco C, Durante M, Graeff C.

Phys Med Biol. 2018 Jan 17;63(2):025034. doi: 10.1088/1361-6560/aa9c62.

PMID:
29165322
20.

Modeling Radiation Effects of Ultrasoft X Rays on the Basis of Amorphous Track Structure.

Buch T, Scifoni E, Krämer M, Durante M, Scholz M, Friedrich T.

Radiat Res. 2018 Jan;189(1):32-43. doi: 10.1667/RR14653.1. Epub 2017 Oct 26.

PMID:
29073360

Supplemental Content

Loading ...
Support Center